Annual Current Liabilities
$3.59 M
+$1.74 M+94.10%
December 31, 2023
Summary
- As of February 8, 2025, TENX annual total current liabilities is $3.59 million, with the most recent change of +$1.74 million (+94.10%) on December 31, 2023.
- During the last 3 years, TENX annual current liabilities has risen by +$1.47 million (+69.25%).
- TENX annual current liabilities is now -42.15% below its all-time high of $6.20 million, reached on December 31, 2016.
Performance
TENX Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$2.56 M
+$820.90 K+47.16%
September 30, 2024
Summary
- As of February 8, 2025, TENX quarterly total current liabilities is $2.56 million, with the most recent change of +$820.90 thousand (+47.16%) on September 30, 2024.
- Over the past year, TENX quarterly current liabilities has increased by +$531.10 thousand (+26.15%).
- TENX quarterly current liabilities is now -58.98% below its all-time high of $6.24 million, reached on March 31, 2016.
Performance
TENX Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
TENX Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +94.1% | +26.1% |
| 3 y3 years | +69.3% | +211.0% |
| 5 y5 years | +129.1% | +211.0% |
TENX Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +129.3% | -28.6% | +325.4% |
| 5 y | 5-year | at high | +129.3% | -28.6% | +325.4% |
| alltime | all time | -42.1% | >+9999.0% | -59.0% | >+9999.0% |
Tenax Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.56 M(+47.2%) |
| Jun 2024 | - | $1.74 M(-14.3%) |
| Mar 2024 | - | $2.03 M(-43.4%) |
| Dec 2023 | $3.59 M(+94.1%) | $3.59 M(+495.6%) |
| Sep 2023 | - | $602.20 K(-26.9%) |
| Jun 2023 | - | $823.80 K(-16.3%) |
| Mar 2023 | - | $983.90 K(-46.8%) |
| Dec 2022 | $1.85 M(+18.1%) | $1.85 M(+167.9%) |
| Sep 2022 | - | $689.80 K(-52.3%) |
| Jun 2022 | - | $1.45 M(-26.8%) |
| Mar 2022 | - | $1.98 M(+26.4%) |
| Dec 2021 | $1.56 M(-26.2%) | $1.56 M(+7.0%) |
| Sep 2021 | - | $1.46 M(+24.4%) |
| Jun 2021 | - | $1.18 M(-18.0%) |
| Mar 2021 | - | $1.43 M(-32.3%) |
| Dec 2020 | $2.12 M(-16.3%) | $2.12 M(+53.6%) |
| Sep 2020 | - | $1.38 M(-36.9%) |
| Jun 2020 | - | $2.19 M(-12.7%) |
| Mar 2020 | - | $2.51 M(-1.1%) |
| Dec 2019 | $2.53 M(+61.7%) | $2.53 M(+124.3%) |
| Sep 2019 | - | $1.13 M(+20.3%) |
| Jun 2019 | - | $938.10 K(-7.5%) |
| Mar 2019 | - | $1.01 M(-35.2%) |
| Dec 2018 | $1.57 M(+55.2%) | $1.57 M(+203.3%) |
| Sep 2018 | - | $516.20 K(-34.9%) |
| Jun 2018 | - | $792.80 K(+154.9%) |
| Mar 2018 | - | $311.00 K(-69.2%) |
| Dec 2017 | $1.01 M(-83.7%) | $1.01 M(+20.3%) |
| Sep 2017 | - | $838.60 K(-61.6%) |
| Jun 2017 | - | $2.18 M(-56.7%) |
| Mar 2017 | - | $5.04 M(-18.7%) |
| Dec 2016 | $6.20 M(+34.7%) | $6.20 M(+22.6%) |
| Sep 2016 | - | $5.06 M(-4.2%) |
| Jun 2016 | - | $5.28 M(-15.5%) |
| Mar 2016 | - | $6.24 M(+75.3%) |
| Dec 2015 | $4.60 M(+1.9%) | - |
| Oct 2015 | - | $3.56 M(+9.5%) |
| Jul 2015 | - | $3.25 M(-27.9%) |
| Apr 2015 | $4.52 M(+75.7%) | $4.52 M(+57.5%) |
| Jan 2015 | - | $2.87 M(-21.9%) |
| Oct 2014 | - | $3.67 M(+93.8%) |
| Jul 2014 | - | $1.90 M(-26.3%) |
| Apr 2014 | $2.57 M(+34.6%) | $2.57 M(-28.9%) |
| Jan 2014 | - | $3.61 M(+144.7%) |
| Oct 2013 | - | $1.48 M(-68.7%) |
| Jul 2013 | - | $4.71 M(+146.9%) |
| Apr 2013 | $1.91 M(-38.9%) | $1.91 M(-4.1%) |
| Jan 2013 | - | $1.99 M(+48.0%) |
| Oct 2012 | - | $1.35 M(-66.4%) |
| Jul 2012 | - | $4.00 M(+27.9%) |
| Apr 2012 | $3.13 M | $3.13 M(-46.2%) |
| Jan 2012 | - | $5.81 M(+177.2%) |
| Oct 2011 | - | $2.10 M(-7.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jul 2011 | - | $2.27 M(+3.8%) |
| Apr 2011 | $2.18 M(+56.0%) | $2.18 M(+28.1%) |
| Jan 2011 | - | $1.70 M(+16.3%) |
| Oct 2010 | - | $1.47 M(+14.5%) |
| Jul 2010 | - | $1.28 M(-8.6%) |
| Apr 2010 | $1.40 M(+195.3%) | $1.40 M(+17.0%) |
| Jan 2010 | - | $1.20 M(-27.5%) |
| Oct 2009 | - | $1.65 M(+194.0%) |
| Jul 2009 | - | $560.80 K(+18.4%) |
| Apr 2009 | $473.80 K(+78.8%) | $473.80 K(-21.1%) |
| Jan 2009 | - | $600.40 K(+487.5%) |
| Oct 2008 | - | $102.20 K(-82.3%) |
| Jul 2008 | - | $577.90 K(+118.1%) |
| Apr 2008 | $265.00 K(-85.6%) | $265.00 K(-89.1%) |
| Jan 2008 | - | $2.42 M(+1.1%) |
| Oct 2007 | - | $2.39 M(+4.8%) |
| Jul 2007 | - | $2.29 M(+23.8%) |
| Apr 2007 | $1.85 M(+334.7%) | $1.85 M(+16.8%) |
| Jan 2007 | - | $1.58 M(+41.1%) |
| Oct 2006 | - | $1.12 M(+32.5%) |
| Jul 2006 | - | $845.10 K(+99.0%) |
| Apr 2006 | $424.60 K(+35.3%) | $424.60 K(+182.9%) |
| Jan 2006 | - | $150.10 K(+31.8%) |
| Oct 2005 | - | $113.90 K(+19.8%) |
| Jul 2005 | - | $95.10 K(-69.7%) |
| Apr 2005 | $313.90 K(+6.9%) | $313.90 K(-13.2%) |
| Jan 2005 | - | $361.50 K(-14.0%) |
| Oct 2004 | - | $420.40 K(+23.6%) |
| Jul 2004 | - | $340.00 K(+15.8%) |
| Apr 2004 | $293.70 K(+1925.5%) | $293.70 K(-12.0%) |
| Jan 2004 | - | $333.80 K(+544.4%) |
| Oct 2003 | - | $51.80 K(-95.1%) |
| Jul 2003 | - | $1.07 M(+7252.4%) |
| Apr 2003 | $14.50 K(-91.9%) | $14.50 K(-82.2%) |
| Jan 2003 | - | $81.50 K(-28.1%) |
| Oct 2002 | - | $113.40 K(-14.2%) |
| Jul 2002 | - | $132.10 K(-26.2%) |
| Apr 2002 | $179.10 K(-48.0%) | $179.10 K(-55.0%) |
| Jan 2002 | - | $398.10 K(+14.0%) |
| Oct 2001 | - | $349.30 K(-11.1%) |
| Jul 2001 | - | $392.70 K(+14.1%) |
| Apr 2001 | $344.10 K(-0.4%) | $344.10 K(+16.6%) |
| Jan 2001 | - | $295.20 K(-0.5%) |
| Oct 2000 | - | $296.60 K(-12.3%) |
| Jul 2000 | - | $338.30 K(-2.1%) |
| Apr 2000 | $345.40 K(-42.4%) | $345.40 K(-30.9%) |
| Jan 2000 | - | $500.00 K(0.0%) |
| Oct 1999 | - | $500.00 K(0.0%) |
| Jul 1999 | - | $500.00 K |
| Apr 1999 | $600.00 K(+12.9%) | - |
| Apr 1998 | $531.30 K(-11.6%) | - |
| Apr 1997 | $600.70 K(-38.4%) | - |
| Apr 1996 | $975.00 K | - |
FAQ
- What is Tenax Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Tenax Therapeutics?
- What is Tenax Therapeutics annual current liabilities year-on-year change?
- What is Tenax Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Tenax Therapeutics?
- What is Tenax Therapeutics quarterly current liabilities year-on-year change?
What is Tenax Therapeutics annual total current liabilities?
The current annual current liabilities of TENX is $3.59 M
What is the all time high annual current liabilities for Tenax Therapeutics?
Tenax Therapeutics all-time high annual total current liabilities is $6.20 M
What is Tenax Therapeutics annual current liabilities year-on-year change?
Over the past year, TENX annual total current liabilities has changed by +$1.74 M (+94.10%)
What is Tenax Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of TENX is $2.56 M
What is the all time high quarterly current liabilities for Tenax Therapeutics?
Tenax Therapeutics all-time high quarterly total current liabilities is $6.24 M
What is Tenax Therapeutics quarterly current liabilities year-on-year change?
Over the past year, TENX quarterly total current liabilities has changed by +$531.10 K (+26.15%)